Microlife
SCHWEIZ
Deutsch
Europe
Asia Middle East and North Africa
USA, Latin America
Menu
Headerpictures WatchBP Validation-Pregnancy Flow

Validation and Compliance of a Home Monitoring Device in Pregnancy: Microlife WatchBP Home

Home > WatchBP Produkte > Validations and clinical studies > Validation and compliance of a home monitoring device in pregnancy: Microlife WatchBP home. Hypertens Pregnancy, Chung, 2009

Chung Y., de Greeff A., Shennan A., 2009; 28: 348-59.

Objective

To assess the accuracy and patient compliance in using a novel home blood pressure monitoring device in high-risk pregnancy.

Results

The device achieved a mean difference ± SD of 0.4 ± 7.3/ −0.4 ± 5.5 mmHg (pregnancy) and −2.6 ± 7.0/0.8 ± 4.4 mmHg (preeclampsia) for systolic/ diastolic pressure. Eighty-one percent of women did at least 6 measurements/day and all women did at least 2 measurements/week.

Conclusions

The Microlife WatchBP Home is accurate for use in pregnancy and increases surveillance in compliant patients.

Click here to download the abstract in pdf format.

Related product

Kundendienst

Kontaktieren Sie unseren Kundendienst, wenn Sie bei Ihren Anliegen die Unterstützung unserer freundlichen Händler und Mitarbeiter wünschen.

Support finden
Copyright © 2024 - Microlife Corporation. All rights reserved.